The research the Trust is funding is taking place at the
Royal
Free Hospital in London.
The two avenues of research are -
the treatment of lymphoma (non hodgkins and hodgkins disease) using "Radio Labelled Antibody Targeting and to develop a vaccine to be used to prevent the disease returning once a patient is in remission - the later being the main focus of the research".
In July of 2000 the trials started using the new treatment of radio labeled antibodies - these trials are still going on.
The development of the vaccine is also progressing well and a paper on the subject is about to be published. This research1has advanced to the stage where methods of immunisation are being studied and discussed with all interested parties.
The Trust has purchased equipment to be used in the research at a cost of £4,250.
A 3-year PhD was funded by the Trust and this finished in
September 2000; all the work was on the production of a vaccine.
The funding is continuing paying for a Research Assistant for a
further year.
A Research Nurse for lymphoma patients undergoing trials has been appointed, again funded by the Trust.
Since its inception, the Trust has raised a net figure of £104,700 of which £57,000 has already been donated to the research; but we are approaching a critical stage in the development of the vaccine. Trials consist of 10 patients and the estimated cost will be in the region of £15,000 per patient.
The Trust has to raise this money.